FITZGERALD PHARMACOLOGY MIDTERM PRACTICE
QUESTIONS AND CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES 2026 Q&A | INSTANT
DOWNLOAD PDF
,CORE DOMAINS
Pharmacokinetics: Absorption, Distribution, Metabolism, Elimination
Pharmacodynamics: Receptor Theory, Agonists, Antagonists
Drug Development and Clinical Trial Phases
Pharmacogenomics and CYP450 Interactions
Age-Related Pharmacokinetic Changes
Cardiovascular Pharmacology
Endocrine Pharmacology
Antimicrobial Pharmacology
Neurological and Psychiatric Pharmacology
Gastrointestinal and Anti-Inflammatory Pharmacology
Therapeutic Drug Monitoring and Index
Adverse Drug Reactions and Toxicity
Drug-Drug Interactions and Chelation
Prescribing in Special Populations
INTRODUCTION
The Fitzgerald Pharmacology Midterm Examination assesses the
advanced practice nursing student's mastery of pharmacologic
principles essential for safe and effective prescribing. It evaluates
understanding of pharmacokinetic processes, pharmacodynamic
mechanisms, drug development phases, and clinical application across
diverse patient populations. The examination employs multiple-choice
questions to test foundational theory, applied professional knowledge,
and critical decision-making. Emphasis is placed on drug interactions,
age-related changes, therapeutic monitoring, and evidence-based
prescribing. This assessment prepares candidates for autonomous
pharmacologic management in primary care and specialty settings.
,SECTION ONE: QUESTIONS 1–200
1. SGLT2 inhibitors exert their clinical effect by:
A. Increasing glucose excretion in the urine
B. Decreasing glucose absorption in the gut
C. Stimulating insulin release from the pancreas
D. Enhancing peripheral glucose uptake
A. Increasing glucose excretion in the urine
RATIONALE: SGLT2 inhibitors block the sodium-glucose
cotransporter 2 in the proximal renal tubule, reducing glucose
reabsorption and increasing urinary glucose excretion. This mechanism
is independent of insulin secretion or sensitivity.
2. A drug's mechanism of action is part of its:
A. Pharmacokinetics
B. Therapeutic transformation
C. Pharmacodynamics
D. Metabolism
C. Pharmacodynamics
RATIONALE: Pharmacodynamics describes what the drug does to
the body, including its mechanism of action, receptor interactions, and
therapeutic effects. Pharmacokinetics describes what the body does to
the drug (absorption, distribution, metabolism, elimination).
, 3. The process of absorption, distribution, metabolism and
elimination of a drug is known as:
A. Therapeutic transformation
B. Drug interactions study
C. Pharmacokinetics
D. Pharmacodynamics
C. Pharmacokinetics
RATIONALE: Pharmacokinetics encompasses the four major
processes: absorption (how the drug enters the bloodstream),
distribution (how it moves to tissues), metabolism (how it is
biotransformed), and elimination (how it is removed from the body). It is
often summarized as ADME.
4. Which of the following would best describe a pharmacodynamic
study?
A. Determining the half-life of a specific medication dose
B. Determining the effect of a specific medication dose in treating a
disease
C. Determining the Cmax of various medication doses
D. Determining the AUC of various medication doses
B. Determining the effect of a specific medication dose in treating a
disease
RATIONALE: Pharmacodynamic studies assess the relationship
between drug concentration and its therapeutic effect (what the drug
QUESTIONS AND CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES 2026 Q&A | INSTANT
DOWNLOAD PDF
,CORE DOMAINS
Pharmacokinetics: Absorption, Distribution, Metabolism, Elimination
Pharmacodynamics: Receptor Theory, Agonists, Antagonists
Drug Development and Clinical Trial Phases
Pharmacogenomics and CYP450 Interactions
Age-Related Pharmacokinetic Changes
Cardiovascular Pharmacology
Endocrine Pharmacology
Antimicrobial Pharmacology
Neurological and Psychiatric Pharmacology
Gastrointestinal and Anti-Inflammatory Pharmacology
Therapeutic Drug Monitoring and Index
Adverse Drug Reactions and Toxicity
Drug-Drug Interactions and Chelation
Prescribing in Special Populations
INTRODUCTION
The Fitzgerald Pharmacology Midterm Examination assesses the
advanced practice nursing student's mastery of pharmacologic
principles essential for safe and effective prescribing. It evaluates
understanding of pharmacokinetic processes, pharmacodynamic
mechanisms, drug development phases, and clinical application across
diverse patient populations. The examination employs multiple-choice
questions to test foundational theory, applied professional knowledge,
and critical decision-making. Emphasis is placed on drug interactions,
age-related changes, therapeutic monitoring, and evidence-based
prescribing. This assessment prepares candidates for autonomous
pharmacologic management in primary care and specialty settings.
,SECTION ONE: QUESTIONS 1–200
1. SGLT2 inhibitors exert their clinical effect by:
A. Increasing glucose excretion in the urine
B. Decreasing glucose absorption in the gut
C. Stimulating insulin release from the pancreas
D. Enhancing peripheral glucose uptake
A. Increasing glucose excretion in the urine
RATIONALE: SGLT2 inhibitors block the sodium-glucose
cotransporter 2 in the proximal renal tubule, reducing glucose
reabsorption and increasing urinary glucose excretion. This mechanism
is independent of insulin secretion or sensitivity.
2. A drug's mechanism of action is part of its:
A. Pharmacokinetics
B. Therapeutic transformation
C. Pharmacodynamics
D. Metabolism
C. Pharmacodynamics
RATIONALE: Pharmacodynamics describes what the drug does to
the body, including its mechanism of action, receptor interactions, and
therapeutic effects. Pharmacokinetics describes what the body does to
the drug (absorption, distribution, metabolism, elimination).
, 3. The process of absorption, distribution, metabolism and
elimination of a drug is known as:
A. Therapeutic transformation
B. Drug interactions study
C. Pharmacokinetics
D. Pharmacodynamics
C. Pharmacokinetics
RATIONALE: Pharmacokinetics encompasses the four major
processes: absorption (how the drug enters the bloodstream),
distribution (how it moves to tissues), metabolism (how it is
biotransformed), and elimination (how it is removed from the body). It is
often summarized as ADME.
4. Which of the following would best describe a pharmacodynamic
study?
A. Determining the half-life of a specific medication dose
B. Determining the effect of a specific medication dose in treating a
disease
C. Determining the Cmax of various medication doses
D. Determining the AUC of various medication doses
B. Determining the effect of a specific medication dose in treating a
disease
RATIONALE: Pharmacodynamic studies assess the relationship
between drug concentration and its therapeutic effect (what the drug
